ADC Photosensitivity: Detailing Methodologies to Adapt Manufacturing & Site Requirements to Combat Payload-Specific Photodegradation - 17th World ADC San Diego

Your Flagship Event Driving ADC Innovation, Insights & Connections

Register by Friday, August 7 & Save up to $600

Day

Hour

Minute

Second

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

ADC Photosensitivity: Detailing Methodologies to Adapt Manufacturing & Site Requirements to Combat Payload-Specific Photodegradation

2:30 pm - Monday 12th October 2026

Investigating ADC molecular photosensitivity during manufacturing, focusing on payload specific observations at specific wavelengths
Laying out opportunities to control manufacturing and minimize ADC DS photodegradation
Utilizing learnings to set expectations and minimize ADC photodegradation across manufacturing sites

Speakers:

Nicole Taylor

Nicole Taylor

Principal Scientist, Drug Product Development

Bristol Myers Squibb